Peptide profile
Abaloparatide
Parathyroid hormone 1 receptor agonist
Approved medicines exist
Science, with its context intact.What to knowThe evidence
The evidence
in perspective.
Tymlos is an FDA-approved medicine for defined osteoporosis populations. Approval applies to the labeled product and does not establish a broad regenerative benefit.
View the supporting source- Research area
- Endocrine
- Biological target or mechanism
- Parathyroid hormone 1 receptor agonist
- Evidence context
- Approved medicines exist
- Availability
- Availability requires pharmacy review
From information to a conversationClinical decisions stay
Clinical decisions stay
with clinical professionals.
This profile is a research reference. Your prescriber and pharmacy assess the relevant clinical and dispensing pathway. Inclusion here is not an offer to sell this compound.
